FDA slammed over Aduhelm OK as Biogen takes heat for $56k price tag
pharmaphorum
JUNE 8, 2021
Dementia specialist Prof Robert Howard of University College London (UCL) was also damning in his assessment of the decision, saying that the FDA has “sidestepped available clinical trial outcomes data that indicate the drug probably doesn’t work.”
Let's personalize your content